[{"address1": "Perryville III Building", "address2": "Suite 220 53 Frontage Road", "city": "Hampton", "state": "NJ", "zip": "08827", "country": "United States", "phone": "908 200 7500", "fax": "908 454 1911", "website": "https://www.celldex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.", "fullTimeEmployees": 160, "companyOfficers": [{"maxAge": 1, "name": "Mr. Anthony S. Marucci M.B.A.", "age": 61, "title": "Founder, President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 1268869, "exercisedValue": 0, "unexercisedValue": 11412833}, {"maxAge": 1, "name": "Dr. Tibor  Keler Ph.D.", "age": 64, "title": "Founder, Chief Scientific Officer & Executive VP", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 810394, "exercisedValue": 0, "unexercisedValue": 6456486}, {"maxAge": 1, "name": "Mr. Sam  Martin", "age": 52, "title": "Senior VP, CFO, Secretary & Treasurer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 676874, "exercisedValue": 0, "unexercisedValue": 4388114}, {"maxAge": 1, "name": "Dr. Margo  Heath-Chiozzi M.D.", "age": 66, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 667214, "exercisedValue": 0, "unexercisedValue": 4900492}, {"maxAge": 1, "name": "Dr. Diane C. Young M.D.", "age": 66, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 696453, "exercisedValue": 0, "unexercisedValue": 2722212}, {"maxAge": 1, "name": "Prof. Joseph P. Schlessinger Ph.D.", "age": 78, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1945, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Cavanaugh", "age": 48, "title": "Senior Vice President of Corporate Affairs & Administration", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Freddy A. Jimenez Esq.", "age": 54, "title": "Senior VP & General Counsel", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 579698, "exercisedValue": 0, "unexercisedValue": 944122}, {"maxAge": 1, "name": "Dr. Ronald A. Pepin", "age": 67, "title": "Chief Business Officer & Senior VP", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 441839, "exercisedValue": 0, "unexercisedValue": 2023453}, {"maxAge": 1, "name": "Ms. Elizabeth  Crowley", "age": 51, "title": "Chief Product Development Officer & Senior VP", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 507236, "exercisedValue": 0, "unexercisedValue": 343933}], "auditRisk": 1, "boardRisk": 2, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 1, "governanceEpochDate": 1726617600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.avantimmune.com/", "maxAge": 86400, "priceHint": 2, "previousClose": 41.16, "open": 41.13, "dayLow": 40.45, "dayHigh": 41.88, "regularMarketPreviousClose": 41.16, "regularMarketOpen": 41.13, "regularMarketDayLow": 40.45, "regularMarketDayHigh": 41.88, "beta": 1.563, "forwardPE": -14.027211, "volume": 1389935, "regularMarketVolume": 1389935, "averageVolume": 736825, "averageVolume10days": 857140, "averageDailyVolume10Day": 857140, "bid": 41.22, "ask": 41.31, "bidSize": 100, "askSize": 500, "marketCap": 2733700608, "fiftyTwoWeekLow": 22.11, "fiftyTwoWeekHigh": 53.18, "priceToSalesTrailing12Months": 329.24252, "fiftyDayAverage": 38.507, "twoHundredDayAverage": 38.7565, "currency": "USD", "enterpriseValue": 1933768448, "floatShares": 66104642, "sharesOutstanding": 66287600, "sharesShort": 8571341, "sharesShortPriorMonth": 8397023, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.1293, "heldPercentInsiders": 0.00299, "heldPercentInstitutions": 1.07312, "shortRatio": 12.03, "shortPercentOfFloat": 0.1496, "impliedSharesOutstanding": 66287600, "bookValue": 12.276, "priceToBook": 3.3594005, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -150216000, "trailingEps": -2.75, "forwardEps": -2.94, "lastSplitFactor": "1:15", "lastSplitDate": 1549843200, "enterpriseToRevenue": 232.9, "enterpriseToEbitda": -12.071, "52WeekChange": 0.5959753, "SandP52WeekChange": 0.31472707, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLDX", "underlyingSymbol": "CLDX", "shortName": "Celldex Therapeutics, Inc.", "longName": "Celldex Therapeutics, Inc.", "firstTradeDateEpochUtc": 516547800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "467427db-31ce-3688-87cf-dec0758b5a4b", "messageBoardId": "finmb_9620565", "gmtOffSetMilliseconds": -14400000, "currentPrice": 41.24, "targetHighPrice": 90.0, "targetLowPrice": 37.0, "targetMeanPrice": 67.0, "targetMedianPrice": 68.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 802316992, "totalCashPerShare": 12.104, "ebitda": -160192992, "totalDebt": 2385000, "quickRatio": 29.064, "currentRatio": 29.358, "totalRevenue": 8303000, "debtToEquity": 0.293, "revenuePerShare": 0.148, "returnOnAssets": -0.17828, "returnOnEquity": -0.27532, "freeCashflow": -56806876, "operatingCashflow": -121491000, "revenueGrowth": 8.321, "operatingMargins": -18.54163, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-23"}]